+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Tumor Targeting Peptides Market - Global Forecast 2025-2030- Product Image
Tumor Targeting Peptides Market - Global Forecast 2025-2030- Product Image
Sale

Tumor Targeting Peptides Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6126292
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The tumor targeting peptides market is rapidly advancing as oncology stakeholders demand higher diagnostic precision and safer, more effective therapies. Driven by innovations in peptide engineering and strategic collaborations, the sector is evolving toward integrated solutions across diagnostics and treatment, positioning itself at the forefront of precision medicine.

Market Snapshot: Tumor Targeting Peptides Market Overview

The global tumor targeting peptides market is experiencing robust growth, propelled by increasing demand for targeted cancer diagnostics and therapeutics. Advances in peptide synthesis, biomarker identification, and multifunctional platforms are reshaping how malignant tissues are detected and treated. With a dynamic competitive landscape and intensifying research investment, tumor targeting peptides are becoming foundational in the next generation of oncology solutions. The market encompasses a wide range of peptide types, applications, and regional influences, amplifying both complexity and opportunity for stakeholders. Primary keyword: tumor targeting peptides market.

Scope & Segmentation of the Tumor Targeting Peptides Market

  • Application: Diagnostics, Biomarker Screening, Liquid Biopsy, Imaging, Magnetic Resonance Imaging, Optical Imaging, Positron Emission Tomography, Therapeutics, Immunotherapy, Radiotherapeutics, Targeted Drug Delivery
  • Peptide Types: Cyclic Peptides, Linear Peptides, Peptidomimetics, Self Assembling Peptides
  • Mechanisms: Active Targeting, Passive Targeting
  • Development Stages: Approved, Phase I, Phase II, Phase III, Preclinical
  • Delivery Routes: Intratumoral, Intravenous, Oral, Subcutaneous
  • End Users: Diagnostic Centers, Hospitals, Pharmaceutical Companies, Research Institutes
  • Geographic Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Italy, Spain, UAE, South Africa), and Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia)
  • Key Industry Participants: Novartis AG, Pfizer Inc., Roche Holding AG, Merck & Co., Inc., Amgen Inc., AstraZeneca PLC, Eli Lilly and Company, PeptiDream Inc., Bicycle Therapeutics PLC, Medigene AG

Key Takeaways for Senior Decision-Makers

  • Convergence of peptide engineering, digital lead optimization, and multifunctional platforms is driving innovation and differentiation in the tumor targeting peptides sector.
  • Collaborative models among academic institutions, biopharma firms, and specialized manufacturers are accelerating the transition from discovery to clinical application and reducing technical and regulatory risks.
  • Policy changes, including recent US tariff measures, necessitate new supply chain strategies, localized manufacturing, and increased investment in automation for both cost control and risk mitigation.
  • Regional strategies must account for distinctive regulatory, reimbursement, and research infrastructure differences across the Americas, EMEA, and Asia-Pacific, with customized approaches vital for market entry and commercialization success.
  • Emphasis on talent development, process standardization, and real-world evidence generation will position organizations to capitalize on emerging trends and strengthen reimbursement cases.
  • Broad segmentation across applications, peptide variants, mechanisms, and end users supports informed investment and partnership decisions for sustained competitive positioning.

Tariff Impact on the Global Tumor Targeting Peptides Market

Recent US tariffs implemented in 2025 have driven up input costs for peptide building blocks and analytical reagents, leading supply chain managers to diversify sourcing and consider alternative suppliers. Organizations are reevaluating logistics, developing localized manufacturing solutions, and engaging in hedging practices to mitigate these cost pressures. Process optimization and automation investments are increasing to maintain program timelines, mitigate tariff-induced volatility, and preserve drug development pipeline integrity.

Methodology & Data Sources

This analysis combines primary and secondary research, including consultations with experts in peptide chemistry, clinical oncology, regulation, and supply chain management. Data points are sourced from peer-reviewed literature, patent and company filings, industry white papers, and validated procurement databases. Insights undergo expert validation and triangulation for accuracy and applicability.

Why This Report Matters

  • Provides actionable insights for strategic planning, investment, and cross-sector partnerships in a complex and rapidly evolving landscape.
  • Clarifies key regional, regulatory, and technological dynamics, enabling relevant go-to-market strategies and risk management.
  • Supports leadership in identifying and capitalizing on new opportunities across diagnostic and therapeutic peptide applications.

Conclusion

The tumor targeting peptides market is shaping new paradigms in oncology by integrating diagnostics and therapeutics with precision and scalability. Leaders who adapt to technology advances, evolving supply chains, and market complexities are best positioned for success in this transformative sector.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Development of multifunctional peptide conjugates for simultaneous tumor targeting and immune checkpoint modulation
5.2. Integration of radiolabeled peptides with PET imaging to enable precise tumor detection and monitoring
5.3. Emergence of peptide-based drug conjugates incorporating novel cytotoxic payloads for targeted cancer therapy
5.4. Advancement of tumor-penetrating peptide designs to improve deep tissue delivery and overcome stromal barriers
5.5. Utilization of AI-driven peptide library screening to accelerate discovery of high-affinity tumor homing ligands
5.6. Application of dual-targeting peptides combining receptor binding and metabolic pathway inhibition to enhance selectivity
5.7. Growth of biodegradable nanoparticle-peptide hybrid systems for controlled release and reduced systemic toxicity
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Tumor Targeting Peptides Market, by Application
8.1. Introduction
8.2. Diagnostics
8.2.1. Biomarker Screening
8.2.2. Liquid Biopsy
8.3. Imaging
8.3.1. Magnetic Resonance Imaging
8.3.2. Optical Imaging
8.3.3. Positron Emission Tomography
8.4. Therapeutics
8.4.1. Immunotherapy
8.4.2. Radiotherapeutics
8.4.3. Targeted Drug Delivery
9. Tumor Targeting Peptides Market, by Peptide Type
9.1. Introduction
9.2. Cyclic Peptides
9.3. Linear Peptides
9.4. Peptidomimetics
9.5. Self Assembling Peptides
10. Tumor Targeting Peptides Market, by Mechanism
10.1. Introduction
10.2. Active Targeting
10.3. Passive Targeting
11. Tumor Targeting Peptides Market, by Development Stage
11.1. Introduction
11.2. Approved
11.3. Phase I
11.4. Phase II
11.5. Phase III
11.6. Preclinical
12. Tumor Targeting Peptides Market, by Delivery Route
12.1. Introduction
12.2. Intratumoral
12.3. Intravenous
12.4. Oral
12.5. Subcutaneous
13. Tumor Targeting Peptides Market, by End User
13.1. Introduction
13.2. Diagnostic Centers
13.3. Hospitals
13.4. Pharmaceutical Companies
13.5. Research Institutes
14. Americas Tumor Targeting Peptides Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Tumor Targeting Peptides Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Tumor Targeting Peptides Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Novartis AG
17.3.2. Pfizer Inc.
17.3.3. Roche Holding AG
17.3.4. Merck & Co., Inc.
17.3.5. Amgen Inc.
17.3.6. AstraZeneca PLC
17.3.7. Eli Lilly and Company
17.3.8. PeptiDream Inc.
17.3.9. Bicycle Therapeutics PLC
17.3.10. Medigene AG
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. TUMOR TARGETING PEPTIDES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC TUMOR TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC TUMOR TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. TUMOR TARGETING PEPTIDES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. TUMOR TARGETING PEPTIDES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. TUMOR TARGETING PEPTIDES MARKET: RESEARCHAI
FIGURE 28. TUMOR TARGETING PEPTIDES MARKET: RESEARCHSTATISTICS
FIGURE 29. TUMOR TARGETING PEPTIDES MARKET: RESEARCHCONTACTS
FIGURE 30. TUMOR TARGETING PEPTIDES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. TUMOR TARGETING PEPTIDES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY BIOMARKER SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY BIOMARKER SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY RADIOTHERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY RADIOTHERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY TARGETED DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY TARGETED DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY CYCLIC PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY CYCLIC PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY LINEAR PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY LINEAR PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDOMIMETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDOMIMETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY SELF ASSEMBLING PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY SELF ASSEMBLING PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY ACTIVE TARGETING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY ACTIVE TARGETING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PASSIVE TARGETING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PASSIVE TARGETING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPROVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPROVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY INTRATUMORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY INTRATUMORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL TUMOR TARGETING PEPTIDES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS TUMOR TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES TUMOR TARGETING PEPTIDES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 130. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 131. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 132. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 133. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 134. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 135. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 136. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 137. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 138. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 139. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 140. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 141. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 142. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 143. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. CANADA TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 148. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 149. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 150. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 151. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 156. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 157. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 160. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. MEXICO TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA TUMOR TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 240. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 241. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 242. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 243. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 244. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 245. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 248. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 249. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 250. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 251. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 252. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 253. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. GERMANY TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 258. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 259. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 260. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 261. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 262. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 263. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 264. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 265. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 266. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 267. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 268. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 269. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 270. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 271. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. FRANCE TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 294. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 295. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 296. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 297. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 298. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 299. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 300. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 301. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 302. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 303. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 304. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 305. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 306. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 307. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. ITALY TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 312. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 313. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 314. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 315. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 316. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 317. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2018-2024 (USD MILLION)
TABLE 318. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY PEPTIDE TYPE, 2025-2030 (USD MILLION)
TABLE 319. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 320. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 321. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 322. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 323. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 324. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 325. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. SPAIN TUMOR TARGETING PEPTIDES MARKET SIZE, BY END USER, 2025-2030 (USD MI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Tumor Targeting Peptides market report include:
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
  • Merck & Co., Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly and Company
  • PeptiDream Inc.
  • Bicycle Therapeutics PLC
  • Medigene AG

Related Reports

Targeting Peptides Market - Global Forecast 2025-2030 - Product Image

Targeting Peptides Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Bicyclic Peptide Drug Conjugates Market - Global Forecast 2025-2030 - Product Image

Bicyclic Peptide Drug Conjugates Market - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Peptide Drug Conjugate Market, Drug Sales, Price, Dosage & Clinical Trials Insight 2030 - Product Image

Peptide Drug Conjugate Market, Drug Sales, Price, Dosage & Clinical Trials Insight 2030

  • Report
  • 120 Pages
  • Global
From
Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 - Product Image

Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030

  • Report
  • 600 Pages
  • Global
From
Antitumor Peptide Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Antitumor Peptide Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.